"Chemokine CCL20" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR6 RECEPTORS. It has activity towards DENDRITIC CELLS; T-LYMPHOCYTES; and B-LYMPHOCYTES.
| Descriptor ID |
D054418
|
| MeSH Number(s) |
D12.644.276.374.200.110.880 D12.644.276.374.200.600.880 D12.776.467.374.200.110.880 D12.776.467.374.200.600.880 D23.125.300.110.880 D23.125.300.600.880 D23.469.200.110.880 D23.469.200.600.880 D23.529.374.200.110.880 D23.529.374.200.600.880
|
| Concept/Terms |
Chemokine CCL20- Chemokine CCL20
- CCL20, Chemokine
- Exodus-1 Chemokine
- Chemokine, Exodus-1
- Exodus 1 Chemokine
- Small Inducible Cytokine A20
- MIP-3-alpha
- SCYA20 Chemokine
- Chemokine, SCYA20
- CCL20 Chemokine
- Chemokine, CCL20
- Macrophage Inflammatory Protein 3 alpha
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL20".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL20".
This graph shows the total number of publications written about "Chemokine CCL20" by people in this website by year, and whether "Chemokine CCL20" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL20" by people in Profiles.
-
Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, Wygrecka M, Schaefer L. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 2018 08; 68-69:293-317.
-
Geherin SA, Lee MH, Wilson RP, Debes GF. Ovine skin-recirculating ?d T cells express IFN-? and IL-17 and exit tissue independently of CCR7. Vet Immunol Immunopathol. 2013 Sep 01; 155(1-2):87-97.
-
Igoucheva O, Grazzini M, Pidich A, Kemp DM, Larijani M, Farber M, Lorton J, Rodeck U, Alexeev V. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine. Gene Ther. 2013 Sep; 20(9):939-48.